Atomo Diagnostics awarded A$1.8 mil from the NSW Medical Device Fund 
to develop innovative HIV self test in Australia.

ide Group is pleased to announce the appointment of Marek Swoboda as part of ide's continued commitment to developing new opportunities and realising value across US markets. Marek's appointment marks an exciting phase of progress for ide, signifying an important step towards building a strong international base to deliver cutting edge technologies that make a difference and change lives.

Enigma Diagnostics Ltd, a spin-out company of Ploughshare Innovations, has successfully completed its analytical and diagnostic verification of its FluAB-RSV diagnostic assay on the Enigma® ML system, which looks set to benefit many flu sufferers

Launched at NovaUCD, Dublin, and available in ePub and Kindle versions as well as hardback, Intellectual Property: From Creation to Commercialisation provides a detailed grounding for innovators and researchers.